From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

"This type of prevention can be very useful in controlling infection outbreaks and containing the bird flu pandemic," said an ...

Dr Jörg Schüttrumpf, Grifols Chief Scientific Innovation Officer, stated: “Grifols is excited to contribute its deepening knowledge of therapeutic antibody development, including recombinants, to FcR ...